{
    "Trade/Device Name(s)": [
        "HemosIL Silica Clotting Time"
    ],
    "Submitter Information": "Instrumentation Laboratory Co.",
    "510(k) Number": "K160445",
    "Predicate Device Reference 510(k) Number(s)": [
        "K050221"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GFO"
    ],
    "Summary Letter Date": "February 16, 2016",
    "Summary Letter Received Date": "February 18, 2016",
    "Submission Date": "March 8, 2016",
    "Regulation Number(s)": [
        "21 CFR 864.7925"
    ],
    "Regulation Name(s)": [
        "Partial thromboplastin time tests"
    ],
    "Analyte Class(es)": [
        "hematology",
        "coagulation",
        "immunology"
    ],
    "Analyte(s)": [
        "Lupus Anticoagulants"
    ],
    "Specimen Type(s)": [
        "Citrated plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "IL Coagulation Systems",
        "ACL TOP Family",
        "ACL Futura",
        "ACL Advance",
        "ACL ELITE",
        "ELITE PRO 8/9/10000"
    ],
    "Method(s)/Technology(ies)": [
        "Clotting time assay"
    ],
    "Methodologies": [
        "Clotting time measurement"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for HemosIL Silica Clotting Time assay to detect Lupus Anticoagulants in human citrated plasma using IL Coagulation Systems",
    "Indications for Use Summary": "Intended for detection of Lupus Anticoagulants in human citrated plasma on IL Coagulation Systems via screening and confirmatory reagents for in vitro diagnostic use",
    "fda_folder": "Hematology"
}